Manulife (Manufacturers Life Insurance)
IMDX

Manulife (Manufacturers Life Insurance)’s Insight Molecular Diagnostics IMDX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-869
Closed -$25.9K – 3092
2022
Q1 		$25.9K Sell
869
-473
-35% -$15.1K ﹤0.01% 3058
2021
Q4 		$58 Buy
1,342
+350
+35% +$20.1K ﹤0.01% 3087
2021
Q3 		$71K Sell
992
-1,170
-54% -$108K ﹤0.01% 3119
2021
Q2 		$248K Buy
2,162
+78
+4% +$7.62K ﹤0.01% 2953
2021
Q1 		$216K Sell
2,084
-144
-6% -$13.7K ﹤0.01% 2839
2020
Q4 		$107K Buy
2,228
+596
+37% +$21.9K ﹤0.01% 2947
2020
Q3 		$45K Buy
1,632
+241
+17% +$6.91K ﹤0.01% 2892
2020
Q2 		$90K Buy
+1,391
New +$71.8K ﹤0.01% 2778
2018
Q3 		– Sell
-61
Closed -$3K – 3572
2018
Q2 		$3K Sell
61
-168
-73% -$8.28K ﹤0.01% 4162
2018
Q1 		$10K Buy
229
+132
+136% +$8.72K ﹤0.01% 3921
2017
Q4 		$9K Buy
97
+2
+2% +$225 ﹤0.01% 4005
2017
Q3 		$14K Sell
95
-60
-39% -$6.28K ﹤0.01% 3748
2017
Q2 		$16K Buy
155
+100
+182% +$11.4K ﹤0.01% 3716
2017
Q1 		$6K Hold
55
– – ﹤0.01% 3749
2016
Q4 		$7K Sell
55
-40
-42% -$4.41K ﹤0.01% 3857
2016
Q3 		$9K Hold
95
– – ﹤0.01% 3720
2016
Q2 		$7K Sell
95
-93
-49% -$8.69K ﹤0.01% 3718
2016
Q1 		$18K Buy
+188
New +$16.7K ﹤0.01% 3504

Other funds holding IMDX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s IMDX Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Insight Molecular Diagnostics (IMDX) in Q2 2022, closing a stake of 869 shares — an estimated $25.9K sold.

Manulife (Manufacturers Life Insurance) first reported a position in IMDX in Q1 2016 and held it in 18 quarters. The position peaked at $248K in Q2 2021. 75 funds tracked by Wall St. Rank hold IMDX as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Insight Molecular Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 869 Insight Molecular Diagnostics shares in Q2 2022, an estimated $25.9K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Insight Molecular Diagnostics in Q1 2016 and held it in 18 quarters.
  • Manulife (Manufacturers Life Insurance)'s Insight Molecular Diagnostics position peaked at $248K in Q2 2021.
  • 75 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.